SHH Equity Snapshot

688759 Weekly Equity Report

BEBETTER MED INC

Interactive chart JSON snapshot
Latest Close 30.29 CNY 12 Jun 2026
1W Return -2.9% latest completed week
4W Return -13.0% short-term follow-through
12W Return -20.3% quarterly tape
Trend Breadth 0.0% 0 of 32 weeks active
Volume Ratio 0.7x vs 13-week average
Company Brief

What the company does

BeBetter Med Inc., a biopharmaceutical company, engages in the research and development, and sale of drugs for tumors, autoimmune diseases, and metabolic diseases. It is developing BEBT-908, a PI3K/HDAC dual-target small molecule inhibitor for antitumor; BEBT-209, a CDK4 highly selective CDK4/6 inhibitor for antitumor; BEBT-109, a pan-mutant EGFR inhibitor for antitumor; BEBT-260, a ChK1 inhibitor for antitumor; BEBT-305, a second-generation HSP90 inhibitor for autoimmune disease; BEBT-503, a pan-PPAR agonist for metabolic disease; BEBT-607, a KRAS G12C inhibitor for antitumor; BEBT-808, an oral small molecule GLP-1R full agonist for metabolic disease; BEBT-809, a GPR75 pathway inhibitor …

Snapshot

What the weekly tape is saying

688759 closed the latest completed week at 30.29 CNY. The 4-week return is -13.0% and the 12-week return is -20.3%. Trend Signal is inactive, Market Dynamics is -0.60. Setup signature: Risk-first tape with a 20/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -17.6%
Volume 0.7x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 0 Persistence of active Trend Signal over the last year and current streak.
Momentum 2 Blend of 4-week and 12-week follow-through.
Dynamics 39 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 50 Relative leadership and short-term RS change.
Volume 30 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
36.75 CNY
Vs Trend Line
-17.6%
Fair Value
36.49 CNY
Vs Fair Value
-17.0%
52W High
57.47 CNY
52W Low
27.53 CNY
Drawdown
-47.3%
Range Position
9.2%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -2.9%
4W -13.0%
12W -20.3%
26W -5.6%
52W -

Trend read

Active Streak
0 weeks
52W Active Weeks
0
52W Active Breadth
0.0%
Sector Scope
CN Healthcare
Sector Rank
295 of 486
Sector Percentile
39.4%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.60
4W MD Change
-
Relative Strength
-
4W RS Change
-
Expectation
Negative
Probability
38.02%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
12.4M
13W Average
17.2M
52W Average
25.5M
Vs 13W
0.7x
Vs 52W
0.5x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
5.7%
52W Volatility
14.6%
Upside Weeks
10
Downside Weeks
21
Downside Breadth
67.7%
Avg Gain / Loss
12.8% / -5.4%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
SHH
Country
CN
Sector
Healthcare
Industry
Biotechnology
Currency
CNY
Market Cap
15.5B

Opportunity signals

  • No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 30.29 CNY -2.9% 36.75 CNY 36.49 CNY -0.60 - 12.4M Off
5 Jun 2026 31.18 CNY -4.6% 36.78 CNY 36.69 CNY -0.56 - 21.2M Off
29 May 2026 32.70 CNY -10.9% 36.88 CNY 36.88 CNY -0.59 - 24.6M Off
22 May 2026 36.71 CNY 5.5% - 37.02 CNY -0.42 - 24.2M Off
15 May 2026 34.81 CNY 2.7% - 37.03 CNY - - 20.2M Off
8 May 2026 33.88 CNY 6.5% - 37.12 CNY - - 11.6M Off
1 May 2026 31.81 CNY -9.8% - 37.24 CNY - - 20.2M Off
24 Apr 2026 35.27 CNY -8.6% - 37.46 CNY - - 10.3M Off
17 Apr 2026 38.59 CNY 2.4% - 37.55 CNY - - 15.2M Off
10 Apr 2026 37.68 CNY -6.2% - 37.50 CNY - - 13.4M Off
3 Apr 2026 40.17 CNY 2.2% - 37.49 CNY - - 22.6M Off
27 Mar 2026 39.29 CNY 3.4% - 37.37 CNY - - 15.1M Off
20 Mar 2026 38.00 CNY -3.1% - 37.27 CNY - - 13.3M Off
13 Mar 2026 39.22 CNY -3.7% - 37.23 CNY - - 15.1M Off